Cargando…
Oral treatment with PD-0200347, an α(2)δ ligand, reduces the development of experimental osteoarthritis by inhibiting the chondrocytes metalloproteases and inducible nitric oxide synthase gene expression and synthesis
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2004
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833517/ http://dx.doi.org/10.1186/ar1387 |
| _version_ | 1782178405098192896 |
|---|---|
| author | Boileau, C Martel-Pelletier, J Brunet, J Tardif, G Schrier, D Flory, C Boily, M Pelletier, J-P |
| author_facet | Boileau, C Martel-Pelletier, J Brunet, J Tardif, G Schrier, D Flory, C Boily, M Pelletier, J-P |
| author_sort | Boileau, C |
| collection | PubMed |
| description | |
| format | Text |
| id | pubmed-2833517 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2004 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-28335172010-03-08 Oral treatment with PD-0200347, an α(2)δ ligand, reduces the development of experimental osteoarthritis by inhibiting the chondrocytes metalloproteases and inducible nitric oxide synthase gene expression and synthesis Boileau, C Martel-Pelletier, J Brunet, J Tardif, G Schrier, D Flory, C Boily, M Pelletier, J-P Arthritis Res Ther Poster Presentation BioMed Central 2004 2004-09-13 /pmc/articles/PMC2833517/ http://dx.doi.org/10.1186/ar1387 Text en |
| spellingShingle | Poster Presentation Boileau, C Martel-Pelletier, J Brunet, J Tardif, G Schrier, D Flory, C Boily, M Pelletier, J-P Oral treatment with PD-0200347, an α(2)δ ligand, reduces the development of experimental osteoarthritis by inhibiting the chondrocytes metalloproteases and inducible nitric oxide synthase gene expression and synthesis |
| title | Oral treatment with PD-0200347, an α(2)δ ligand, reduces the development of experimental osteoarthritis by inhibiting the chondrocytes metalloproteases and inducible nitric oxide synthase gene expression and synthesis |
| title_full | Oral treatment with PD-0200347, an α(2)δ ligand, reduces the development of experimental osteoarthritis by inhibiting the chondrocytes metalloproteases and inducible nitric oxide synthase gene expression and synthesis |
| title_fullStr | Oral treatment with PD-0200347, an α(2)δ ligand, reduces the development of experimental osteoarthritis by inhibiting the chondrocytes metalloproteases and inducible nitric oxide synthase gene expression and synthesis |
| title_full_unstemmed | Oral treatment with PD-0200347, an α(2)δ ligand, reduces the development of experimental osteoarthritis by inhibiting the chondrocytes metalloproteases and inducible nitric oxide synthase gene expression and synthesis |
| title_short | Oral treatment with PD-0200347, an α(2)δ ligand, reduces the development of experimental osteoarthritis by inhibiting the chondrocytes metalloproteases and inducible nitric oxide synthase gene expression and synthesis |
| title_sort | oral treatment with pd-0200347, an α(2)δ ligand, reduces the development of experimental osteoarthritis by inhibiting the chondrocytes metalloproteases and inducible nitric oxide synthase gene expression and synthesis |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833517/ http://dx.doi.org/10.1186/ar1387 |
| work_keys_str_mv | AT boileauc oraltreatmentwithpd0200347ana2dligandreducesthedevelopmentofexperimentalosteoarthritisbyinhibitingthechondrocytesmetalloproteasesandinduciblenitricoxidesynthasegeneexpressionandsynthesis AT martelpelletierj oraltreatmentwithpd0200347ana2dligandreducesthedevelopmentofexperimentalosteoarthritisbyinhibitingthechondrocytesmetalloproteasesandinduciblenitricoxidesynthasegeneexpressionandsynthesis AT brunetj oraltreatmentwithpd0200347ana2dligandreducesthedevelopmentofexperimentalosteoarthritisbyinhibitingthechondrocytesmetalloproteasesandinduciblenitricoxidesynthasegeneexpressionandsynthesis AT tardifg oraltreatmentwithpd0200347ana2dligandreducesthedevelopmentofexperimentalosteoarthritisbyinhibitingthechondrocytesmetalloproteasesandinduciblenitricoxidesynthasegeneexpressionandsynthesis AT schrierd oraltreatmentwithpd0200347ana2dligandreducesthedevelopmentofexperimentalosteoarthritisbyinhibitingthechondrocytesmetalloproteasesandinduciblenitricoxidesynthasegeneexpressionandsynthesis AT floryc oraltreatmentwithpd0200347ana2dligandreducesthedevelopmentofexperimentalosteoarthritisbyinhibitingthechondrocytesmetalloproteasesandinduciblenitricoxidesynthasegeneexpressionandsynthesis AT boilym oraltreatmentwithpd0200347ana2dligandreducesthedevelopmentofexperimentalosteoarthritisbyinhibitingthechondrocytesmetalloproteasesandinduciblenitricoxidesynthasegeneexpressionandsynthesis AT pelletierjp oraltreatmentwithpd0200347ana2dligandreducesthedevelopmentofexperimentalosteoarthritisbyinhibitingthechondrocytesmetalloproteasesandinduciblenitricoxidesynthasegeneexpressionandsynthesis |